Josep Malvehy is a consultant dermatologist at the Dermatology Department and director of the Skin Cancer Program at the Hospital Clinic of Barcelona since 2003 and director of the Innovation Program of the “Institut de Medicina i Dermatologia” (ICMID) of the same Hospital. He develops his university activity as professor in masters at the University of Barcelona being accredited as a full professor since 2021 by the "Agència de qualitat Universitaria (AQU)". He is an investigator of the IDIBAPS (Institut d’Investigació August Pi i Sunyer). Special areas of research and innovation are skin cancer diagnostics and treatment, non-invasive techniques of skin cancer diagnosis, artificial intelligence, genetics of melanoma, skin cancer susceptibility, skin carcinogenesis, and teledermatology. He is also involved in research grants in Big Data and AI, biomarkers discovery, and treatment of skin cancer. He is IP of more than 20 research grants and clinical trials He is the author of more than 590 scientific publications in international journals (>29,000 citations; HI 87) J.Malvehy is the President of the European Association of Dermato Oncology (EADO) and Board member of International Societies (EDF, IDS, ) and Scientific Board member of the World Melanoma society.